S2Medical AB
The answer first
Does S2Medical beat the market?
No, S2Medical has not beaten the market over the last year.
Max for seven days
Follow S2Medical with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about S2Medical
Your first answer is free, no account needed.
Do you own S2Medical, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with S2Medical and a few more. Free, no card.
Super Stock+46.3%In short
- S2Medical has fallen 59.0% over the past year, including dividends.
- The largest fall over the past three years was 99.3%. The price is 100.0% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Medium An average company: the accounts are neither especially strong nor weak.
No. 153 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.00
- Asset turnoverSales divided by everything the company owns0.96
- Return on equityProfit divided by equity−100.1%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
- P/BPrice divided by equity0.3
- P/SPrice divided by sales0.2
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 166 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−50.0%
- 6 months−28.9%
- 9 months−64.0%
- 12 months−59.0%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About S2Medical
S2Medical AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 10 employees.
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.


See the full analysis of S2Medical.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card